MHLW Eyes Evaluation Indices and Guidelines to Fuel Rollout of SaMD and Cell & Gene Therapies: Official

January 11, 2022
Hidehito Sekino, Director, Medical Device Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, MHLW The Ministry of Health, Labor and Welfare (MHLW) will accelerate the commercialization of software as a medical device (SaMD) and cell and gene therapies categorized as...read more